DISCLAIMER: This is a working document provided by the Centers for Disease Control and Prevention (CDC) 

technical support contractor, SC&A for use in discussions with the National Institute for Occupational Safety and 

Health (NIOSH) and the Advisory Board on Radiation and Worker Health (ABRWH), including its Working Groups or 

Subcommittees. Documents produced by SC&A, such as memorandum, white paper, draft or working documents are 

not final NIOSH or ABRWH products or positions, unless specifically marked as such. This document prepared by 

SC&A represents its preliminary evaluation on technical issues. 

NOTICE: This document has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 U.S.C. § 552a and has been cleared for distribution. 

Handout

SPR-Approved Document Reviews 

Meeting of the Subcommittee for Procedure Reviews

February 16, 2023

Table 1. Documents reviewed and closed by the SPR

Finding 

date 

Document & 

revision number, 

date

Document title Total

findings

SPR 

closed 

date

Comments ABRWH 

closed date

2/18/2015 DCAS-PER-042, 

rev. 0, 

Nov. 16, 2012

Linde Ceramics 

Plant TBD 

Revision

3 5/16/2016 Not suitable for 

matrix

Not yet 

presented to 

Board

1/10/2017 DCAS-PER-055, 

rev. 0, 

Sept. 12, 2014

TBD-6000 

Revision

2 10/31/2018 Not suitable for 

matrix

Not yet 

presented to 

Board

6/8/2006 NIOSH-OVER0002, rev. 00, 

Oct. 26, 2012

Workplace 

Ingestion

1 2/5/2013 Not suitable for 

matrix

Not yet 

presented to 

Board

11/23/2014 OCAS-PER-009, 

rev. 0, 

March 8, 2007

Target Organs for 

Lymphoma

6 2/18/2015 Not suitable for 

matrix

Not yet 

presented to 

Board

11/13/2013 OCAS-PER-020, 

rev. 0, 

July 31, 2007

Blockson TBD 

Revision

6 11/25/2014 Not suitable for 

matrix

Not yet 

presented to 

Board

6/8/2006 OCAS-PR-007, 

rev. 02, 

April 18, 2005

Dose 

Reconstruction 

Review

9 10/14/2008 Not suitable for 

matrix

Not yet 

presented to 

Board

6/8/2006 ORAUT-OTIB-0011, 

rev. 00, 

June 29, 2004

Technical 

Information 

Bulletin: Tritium 

Calculated and 

Missed Dose 

Estimates

2 10/2/2007 Not suitable for 

matrix

Not yet 

presented to 

Board 

6/8/2006 ORAUT-OTIB-0019, 

rev. 01, 

Oct. 7, 2005

Analysis of 

Coworker 

Bioassay Data for 

Internal Dose 

Assignment

1 10/14/2008 Not suitable for 

matrix

Not yet 

presented to 

Board 

11/5/2013 ORAUT-OTIB-0054, 

rev. 01, 

June 13, 2013

Fission and 

Activation Product 

Assignment for 

Internal DoseRelated Gross 

Beta and Gross 

Gamma Analyses

36 4/28/2015 Not suitable for 

matrix

Not yet 

presented to 

Board 
SC&A, Inc.

SPR-Approved Reviews, page 2 February 16, 2023

NOTICE: This document has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 U.S.C. § 552a and has been cleared for distribution. 

Finding 

date 

Document & 

revision number, 

date

Document title Total

findings

SPR 

closed 

date

Comments ABRWH 

closed date

10/29/2007 ORAUT-OTIB-0057, 

rev. 00, 

May 15, 2006

External Radiation 

Dose Estimates 

for Individuals 

Near the 1958 

Criticality Accident 

at the Oak Ridge 

Y-12 Plant

3 8/8/2011 Not suitable for 

matrix

Not yet 

presented to 

Board 

10/31/2012 ORAUT-PROC0044, rev. 00, 

Oct. 7, 2005

Special Exposure 

Cohort

10 11/20/2017 Not suitable for 

matrix

Not yet 

presented to 

Board

1/17/2005 ORAUT-PROC0090, rev. 00, 

June 21, 2005

Computer 

Assisted 

Telephone 

Interview Process

29 4/28/2015 Not suitable for 

matrix

Not yet 

presented to 

Board 

9/20/2007 ORAUT-PROC0092, rev. 00, 

August 17, 2005

Close-Out 

Interview Process

9 4/28/2015 Not suitable for 

matrix

Not yet 

presented to 

Board

8/17/2007 ORAUT-PROC0031, rev. 01, 

Dec. 15, 2005

Site Profile and 

Technical Basis 

Document 

Development

2 7/9/2013 Pre-review of 

revision 03 

indicated full 

review NA. 

Current revision 

04, 11/5/2012

Not yet 

presented to 

Board 

10/31/2017 DCAS-RPT-005, 

rev. 01, 

August 17, 2018

Alternative 

Dissolution 

Models for 

Insoluble Pu-238

2 2/18/2021 Relevant 

document even 

though RPT 

revised

Not yet 

presented to 

Board 

2/17/2015 DCAS-PER-047, 

rev. 0, 

March 26, 2014

Grand Junction 

Operations Office

4 2/18/2021 Relevant 

document even 

though TBD 

revised

Not yet 

presented to 

Board 

4/16/2013 OCAS-PER-005, 

rev. 0, June 9, 2006

Misinterpreted 

Application of the 

External Dose 

Factor for Hanford 

Dose 

Reconstructions

1 5/16/2016 Relevant 

document even 

though TBD 

revised

Not yet 

presented to 

Board 

8/20/2014 DCAS-PER-045, 

rev. 0, 

May 13, 2013

Aliquippa Forge 

TBD Revision

10 2/15/2022 Residual period 

external and 

internal doses 

increased

Not yet 

presented to 

Board 

10/29/2018 DCAS-PER-076, 

rev. 0, 

February 15, 2017

Aliquippa Forge 

TBD 

0 2/13/2019 Residual period 

internal and 

external doses 

increased

Not yet 

presented to 

Board 

1/26/2019 DCAS-PER-077, 

rev. 0, 

February 28, 2017

Simonds Saw and 

Steel TBD

0 2/13/2019 Uranium intakes 

increased

Not yet 

presented to 

Board

2/17/2015 DCAS-PER-043, 

rev. 0, June 7, 2013

Internal Dosimetry 

Organ, External 

Dosimetry Organ, 

and IREP Model 

Selection by 

ICD-9 Code 

Revision

3 4/28/2015 Revision: 

OTIB-0005 

rev. 06 

(Sept. 2019 for 

ICD-10)

Not yet 

presented to 

Board 
SC&A, Inc.

SPR-Approved Reviews, page 3 February 16, 2023

NOTICE: This document has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 U.S.C. § 552a and has been cleared for distribution. 

Finding 

date 

Document & 

revision number, 

date

Document title Total

findings

SPR 

closed 

date

Comments ABRWH 

closed date

5/22/2017 DCAS-PER-059, 

rev. 0, April 24, 

2015

Norton Company 3 5/25/2022 Residual period 

contamination 

depletion rate 

changed.

Not yet 

presented to 

Board 

1/14/2019 ORAUT-OTIB-0006, 

rev. 05, 

August 13, 2018

Dose 

Reconstruction 

from Occupational 

Medical X-Ray 

Procedures

7 2/15/2022 OTIB-0006, 

rev. 06, issued 

9/27/2019 

resolved last 2 

observations.

Although 

observations 

were closed, 

SC&A’s 2/3/2021 

memo lists 

documentation 

issues that 

should be 

findings.

Not yet 

presented to 

Board 

10/9/2018 DCAS-PER-081, 

rev. 0, 

October 17, 2017

Hooker 

Electrochemical

2 2/13/2019 Presented at 

12/8/2021 Board 

meeting

12/8/2021

6/8/2006 ORAUT-OTIB-0025, 

rev. 00, 

April 5, 2005

Estimation of 

Radium-226 

Activity in the 

Body from Breath 

Radon-222 

Measurements

1 12/11/2007 Presented at 

12/8/2021 Board 

meeting

12/8/2021

10/29/2007 ORAUT-OTIB-0032, 

rev. 00 PC-1, 

Nov. 7, 2006

External Coworker 

Dosimetry Data 

for the Savannah 

River Site

2 5/16/2016 Presented at 

12/8/2021 Board 

meeting

12/8/2021

6/8/2006 ORAUT-OTIB-0033, 

rev. 00, 

April 20, 2005

Application of 

Internal Doses 

Based on 

ClaimantFavorable 

Assumptions for 

Processing as 

Best Estimates

1 10/31/2018 Presented at 

12/8/2021 Board 

meeting

12/8/2021

6/8/2006 ORAUT-PROC0022, rev. 00, 

March 15, 2005

Supplemental 

Requests for DOE 

Information

2 11/20/2017 Presented at 

12/8/2021 Board 

meeting

12/8/2021

1/26/2019 DCAS-PER-080, 

rev. 0, 

August 30, 2017

General Steel 

Industries

1 2/13/2019 Presented at 

4/27/2022 Board 

meeting

4/27/2022

10/9/2018 ORAUT-RPRT0086, rev. 00, 

Sept. 18, 2017

Internal Dosimetry 

Coworker Data 

Completeness 

Test

3 2/13/2019 Presented at 

4/27/2022 Board 

meeting

4/27/2022

12/8/2008 ORAUT-OTIB-0066, 

rev. 01, Oct. 15, 

2020

Calculation of 

Dose from Intakes 

of Special Tritium 

Compounds

4 11/3/2021 Presented at 

4/27/2022 Board 

meeting

4/27/2022
SC&A, Inc.

SPR-Approved Reviews, page 4 February 16, 2023

NOTICE: This document has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 U.S.C. § 552a and has been cleared for distribution. 

Finding 

date 

Document & 

revision number, 

date

Document title Total

findings

SPR 

closed 

date

Comments ABRWH 

closed date

1/3/2017 DCAS-PER-057, 

rev. 0, 

March 11, 2015

General Steel 

Industries

11 (from 

Subtask 4 

review)

11/3/2021 Presented at 

4/27/2022 Board 

meeting

4/27/2022

7/17/2017 DCAS-PER-063, 

rev. 0, 

June 15, 2015

Aluminum 

Company of 

America – 

Pennsylvania 

(ALCOA-PN)

0 11/3/2021 Presented at 

4/27/2022 Board 

meeting

4/27/2022

6/15/2017 DCAS-PER-065, 

rev. 0, 

Nov. 30, 2015

Anaconda 

Program 

Evaluation Report, 

Rev. 0

1 11/2/2021 Presented at 

4/27/2022 Board 

meeting

4/27/2022

1/3/2017 DCAS-PER-064, 

rev. 0, 

Nov. 16, 2015

DuPont Deep 

Water Works

0 10/31/2018 Presented at 

4/27/2022 Board 

meeting

4/27/2022

10/9/2018 DCAS-PER-049, 

rev. 0, 

August 5, 2016

Paducah Gaseous 

Diffusion Plant

0 10/31/2018 Presented at 

8/18/2022 Board 

meeting.

8/18/2022

5/16/2016 OCAS-PER-008, 

rev. 0, 

April 12, 2007

Modification of 

NIOSH-IREP 

Lung Cancer Risk 

Model: Effect of 

“Combined” Lung 

Model on 

Non-compensable 

Lung Cancer 

Claims

2 6/8/2016 Presented at the 

8/18/2022 Board 

meeting

8/18/2022

10/29/2007 OCAS-PER-006, 

rev. 0, 

Sept. 15, 2006

External 

Dosimetry Target 

Organ for Prostate 

Cancer

1 12/9/2008 Presented at the 

8/18/2022 Board 

meeting

8/18/2022

6/8/2006 ORAUT-OTIB-0023, 

rev. 00, 

March 7, 2005

Assignment of 

Missed Neutron 

Doses Based on 

Dosimeter 

Records

8 6/24/2008 Presented at the 

8/18/2022 Board 

meeting

8/18/2022

12/29/2016 DCAS-PER-066, 

rev. 0, 

Nov. 30, 2015

Huntington Pilot 

Plant

1 10/31/2018 Presented at the 

8/18/2022 Board 

meeting

8/18/2022

6/8/2006 ORAUT-OTIB-0014, 

rev. 00, 

June 22, 2004

Technical 

Information 

Bulletin – 

Assignment of 

Environmental 

Internal Doses for 

Employees Not 

Exposed to 

Airborne 

Radionuclides in 

the Workplace

1 4/11/2012 Presented at 

12/8/2022 Board 

meeting

12/8/2022

1/17/2005 ORAUT-PROC0002, rev. 00, 

August 14, 2003

Use of Integrated 

Modules for 

Bioassay Analysis 

(IMBA)

3 7/26/2006 Presented at 

12/8/2022 Board 

meeting

12/8/2022
SC&A, Inc.

SPR-Approved Reviews, page 5 February 16, 2023

NOTICE: This document has been reviewed to identify and redact any information that is protected by the 

Privacy Act 5 U.S.C. § 552a and has been cleared for distribution. 

Finding 

date 

Document & 

revision number, 

date

Document title Total

findings

SPR 

closed 

date

Comments ABRWH 

closed date

6/8/2006 ORAUT-PROC0077, rev. 00, 

March 28, 2005

Dose 

Reconstruction 

Error Tracking and 

Reporting

3 11/7/2007 Presented at 

12/8/2022 Board 

meeting

12/8/2022

10/29/2007 OCAS-PER-003, 

rev. 0, 

January 28, 2005

Evaluation of the 

Effect of Adding 

Ingestion Intakes 

to Bethlehem 

Steel Cases

4 5/16/2016 Presented at 

12/8/2022 Board 

meeting

12/8/2022

12/5/2013 OCAS-PER-025, 

rev. 0, 

Sept. 28, 2007

Huntington Pilot 

Plant TBD 

Revision

4 2/13/2014 Presented at 

12/8/2022 Board 

meeting

12/8/2022

11/25/2014 DCAS-PER-038, 

rev. 0, 

July 24, 2012

Hooker 

Electrochemical 

TBD Revisions

0 11/25/2014 Presented at 

12/8/2022 Board 

meeting

12/8/2022

2/17/2015 DCAS-PER-033, 

rev. 0, 

December 9, 2011

Reduction Pilot 

Plant TBD 

Revision

0 2/17/2015 Presented at 

12/8/2022 Board 

meeting

12/8/2022

Note. ABRWH = Advisory Board on Radiation and Worker Health; ER = evaluation report; ICD = International 

Classification of Diseases; IMBA = Integrated Modules for Bioassay Analysis; IREP = Interactive 

RadioEpidemiological Program; SPR = Subcommittee for Procedure Reviews; SEC = Special Exposure Cohort; 

TBD = technical basis document.